A patient with recurrent hypercortisolism after removal of an ACTH-secreting pituitary adenoma due to an adrenal macronodule

被引:0
|
作者
H. J. L. M. Timmers
E. M. van Ginneken
P. Wesseling
C. G. J. Sweep
A. R. M. M. Hermus
机构
[1] Radboud University,Department of Endocrinology (741)
[2] Nijmegen Medical Center,Department of Pathology
[3] Radboud University,Department of Chemical Endocrinology
[4] Nijmegen Medical Center,undefined
[5] Radboud University,undefined
[6] Nijmegen Medical Center,undefined
来源
Journal of Endocrinological Investigation | 2006年 / 29卷
关键词
Cushing’s disease; pituitary adenoma; adrenal hyperplasia;
D O I
暂无
中图分类号
学科分类号
摘要
A 41-yr-old female was referred for signs and symptoms of Cushing’s syndrome. Cortisol was not suppressed by 1 mg dexamethasone (0.41 μmol/l). Midnight cortisol and ACTH were 0.44 μmol/l and 18 pmol/l, respectively. Urinary cortisol excretion was 250 nmol/24 h (normal between 30 and 150 nmol/24 h). A magnetic resonance imaging (MRI) revealed a pituitary lesion of 7 mm. ACTH and cortisol levels were unaltered by administration of human CRH and high-dose dexamethasone. Inferior sinus petrosus sampling showed CRH-stimulated ACTH levels of 128.4 (left sinus) vs a peripheral level of 19.2 pmol/l, indicating Cushing’s disease. After 4 months of pre-treatment with metyrapone and dexamethasone, endoscopic transsphenoidal resection of an ACTH-positive pituitary adenoma was performed. ACTH levels decreased to 2.6 pmol/l and fasting cortisol was 0.35 μmol/l. Despite clinical regression of Cushing’s syndrome and normalization of urinary cortisol, cortisol was not suppressed by 1 mg dexamethasone (0.30 μmol/l). Ten months post-operatively, signs and symptoms of Cushing’s syndrome reoccurred. A high dose dexamethasone test according to Liddle resulted in undetectable ACTH, but no suppression of cortisol levels, pointing towards adrenal-dependent Cushing’s syndrome. Computed tomography (CT)-scanning showed a left-sided adrenal macronodule. Laparoscopic left adrenalectomy revealed a cortical macronodule (3.5 cm) surrounded by micronodular hyperplasia. Fasting cortisol had decreased to 0.02 μmol/l. Glucocorticoid suppletion was started and tapered over 12 months. Symptoms and signs of hypercortisolism gradually disappeared. This case illustrates, that longstanding ACTH stimulation by a pituitary adenoma can induce unilateral macronodular adrenal hyperplasia with autonomous cortisol production.
引用
收藏
页码:934 / 939
页数:5
相关论文
共 32 条
  • [1] A patient with recurrent hypercortisolism after removal of an ACTH-secreting pituitary adenoma due to an adrenal macronodule
    Timmers, H. J. L. M.
    van Ginneken, E. M.
    Wesseling, P.
    Sweep, C. G. J.
    Hermus, A. R. M. M.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2006, 29 (10) : 934 - 939
  • [2] An ACTH-secreting Pituitary Adenoma Within the Sphenoid Sinus
    Suzuki, Kunihiro
    Hattori, Yoshiyuki
    Aoki, Chie
    Nakano, Ayuko
    Tomizawa, Atsuko
    Kase, Hiroyuki
    Kasai, Kikuo
    INTERNAL MEDICINE, 2010, 49 (08) : 763 - 766
  • [3] Cryptococcal meningitis after transnasal transsphenoidal pituitary microsurgery of ACTH-secreting pituitary adenoma A case report
    Liu, Yang
    Feng, Ming
    Yao, Yong
    Deng, Kan
    Bao, Xinjie
    Liu, Xiaohai
    Wang, Renzhi
    MEDICINE, 2017, 96 (28)
  • [4] Safety of transsphenoidal microsurgical approach in patients with an ACTH-secreting pituitary adenoma
    Donofrio, Carmine Antonio
    Losa, Marco
    Gemma, Marco
    Giudice, Lodoviga
    Barzaghi, Lina Raffaella
    Mortini, Pietro
    ENDOCRINE, 2017, 58 (02) : 303 - 311
  • [5] Pituitary ACTH-secreting adenoma in Addison's disease: A case report
    Fan, Siyuan
    Jiang, Ying
    Yao, Yong
    Wang, Renzhi
    Xing, Bing
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2013, 115 (12) : 2543 - 2546
  • [6] Safety of transsphenoidal microsurgical approach in patients with an ACTH-secreting pituitary adenoma
    Carmine Antonio Donofrio
    Marco Losa
    Marco Gemma
    Lodoviga Giudice
    Lina Raffaella Barzaghi
    Pietro Mortini
    Endocrine, 2017, 58 : 303 - 311
  • [7] Consensus-driven in-hospital cortisol assessment after ACTH-secreting pituitary adenoma resection
    Stolyarov, Yana
    Mirocha, James
    Mamelak, Adam N.
    Ben-Shlomo, Anat
    PITUITARY, 2018, 21 (01) : 41 - 49
  • [8] Rapid disease progression in patient with mismatch-repair deficiency pituitary ACTH-secreting adenoma treated with checkpoint inhibitor pembrolizumab
    Caccese, Mario
    Barbot, Mattia
    Ceccato, Filippo
    Padovan, Marta
    Gardiman, Marina Paola
    Fassan, Matteo
    Denaro, Luca
    Emanuelli, Enzo
    D'Avella, Domenico
    Scaroni, Carla
    Zagonel, Vittorina
    Lombardi, Giuseppe
    ANTI-CANCER DRUGS, 2020, 31 (02) : 199 - 203
  • [9] Case report: ACTH-secreting pituitary carcinoma metastatic to the liver in a patient with a history of atypical pituitary adenoma and Cushing's disease
    Joehlin-Price, Amy S.
    Hardesty, Douglas A.
    Arnold, Christina A.
    Kirschner, Lawrence S.
    Prevedello, Daniel M.
    Lehman, Norman L.
    DIAGNOSTIC PATHOLOGY, 2017, 12
  • [10] Case report: ACTH-secreting pituitary carcinoma metastatic to the liver in a patient with a history of atypical pituitary adenoma and Cushing’s disease
    Amy S. Joehlin-Price
    Douglas A. Hardesty
    Christina A. Arnold
    Lawrence S. Kirschner
    Daniel M. Prevedello
    Norman L. Lehman
    Diagnostic Pathology, 12